Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart AssociationEmelia J. Benjamin, Sally S. Wong, Salim S. Virani et al.|Circulation|2018Cited by 7.2k
Time to Treatment With Intravenous Tissue Plasminogen Activator and Outcome From Acute Ischemic StrokeJeffrey L. Saver, Lee H. Schwamm, Gregg C. Fonarow et al.|JAMA|2013Cited by 869
Timeliness of Tissue-Type Plasminogen Activator Therapy in Acute Ischemic StrokeGregg C. Fonarow, Lee H. Schwamm, Deepak L. Bhatt et al.|Circulation|2011Cited by 576
Get With the Guidelines–Stroke Is Associated With Sustained Improvement in Care for Patients Hospitalized With Acute Stroke or Transient Ischemic AttackLee H. Schwamm, Kenneth A. LaBresh, Gregg C. Fonarow et al.|Circulation|2008Cited by 571
Door-to-Needle Times for Tissue Plasminogen Activator Administration and Clinical Outcomes in Acute Ischemic Stroke Before and After a Quality Improvement InitiativeGregg C. Fonarow, Lee H. Schwamm, Xin Zhao et al.|JAMA|2014Cited by 563